| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/21/2002 | CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 11/21/2002 | CA2447513A1 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 11/21/2002 | CA2447503A1 Dwf12 and mutants thereof |
| 11/21/2002 | CA2447485A1 Chemically assembled nano-scale circuit elements |
| 11/21/2002 | CA2447445A1 Lentil plants having increased resistance to imidazolinone herbicides |
| 11/21/2002 | CA2447444A1 Antisense permeation enhancers |
| 11/21/2002 | CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof |
| 11/21/2002 | CA2447343A1 Method to induce neovascular formation and tissue regeneration |
| 11/21/2002 | CA2447286A1 Random gene unidirectional antisense library |
| 11/21/2002 | CA2447139A1 Specific binding proteins and uses thereof |
| 11/21/2002 | CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 11/21/2002 | CA2447114A1 Human antipneumococcal antibodies from non-human animals |
| 11/21/2002 | CA2447110A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis |
| 11/21/2002 | CA2447052A1 Combined approach to treatment of cancer using a c-myc antisense oligomer |
| 11/21/2002 | CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 11/21/2002 | CA2447017A1 Moraxella(branhamella) catarrhalis antigens |
| 11/21/2002 | CA2447015A1 Insulin producing cells derived from human embryonic stem cells |
| 11/21/2002 | CA2447004A1 Antisense modulation of ptp1b expression |
| 11/21/2002 | CA2446991A1 Agents that regulate apoptosis |
| 11/21/2002 | CA2446859A1 Transgenic animal model of bone mass modulation |
| 11/21/2002 | CA2446821A1 Hbm variants that modulate bone mass and lipid levels |
| 11/21/2002 | CA2446606A1 Inhibitors of dna methyltransferase isoforms |
| 11/21/2002 | CA2446589A1 Methods for treating cancer |
| 11/21/2002 | CA2446582A1 Reagents and methods for modulating dkk-mediated interactions |
| 11/21/2002 | CA2446266A1 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof |
| 11/21/2002 | CA2446180A1 Cytokine polypeptides |
| 11/21/2002 | CA2446130A1 Methods and compositions for making emamectin |
| 11/21/2002 | CA2446075A1 Novel maxizyme |
| 11/21/2002 | CA2446050A1 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules |
| 11/21/2002 | CA2445366A1 Molecules for disease detection and treatment |
| 11/21/2002 | CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 11/21/2002 | CA2443627A1 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 11/21/2002 | CA2442635A1 Gastrokines and derived peptides including inhibitors |
| 11/21/2002 | CA2442144A1 A helper dependent adenoviral vector system and methods for using the same |
| 11/21/2002 | CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 11/20/2002 | EP1258811A1 Exson-intron junction determining device, genetic region determining device, and determining method for them |
| 11/20/2002 | EP1258532A1 Thermostable D-hydantoinase from Bacillus circulans and the application thereof |
| 11/20/2002 | EP1258531A1 Compounds and methods for inhibiting axillary malodour |
| 11/20/2002 | EP1258530A2 Gaba-A receptor subunits (alpha-2, alpha-3, alpha-5, alpha -6, beta-2) and transfected cells expressing them |
| 11/20/2002 | EP1258529A2 FLIP Gene and FLIP Protein |
| 11/20/2002 | EP1258528A1 Expression of membrane proteins using an adenylyl cyclase of Mycobacterium tuberculosis |
| 11/20/2002 | EP1258494A1 Multiprotein complexes from eukaryotes |
| 11/20/2002 | EP1258493A1 Cleavage and polyadenylation complex of precursor mRNA |
| 11/20/2002 | EP1258287A2 Composite material sheet for analysis of substances originating from living body or analogues thereof |
| 11/20/2002 | EP1257829A2 Complementation assay assessing protein solubility and folding |
| 11/20/2002 | EP1257822A1 Her-2 binding antagonists |
| 11/20/2002 | EP1257819A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 11/20/2002 | EP1257818A1 Enzyme-based gprotein-coupled receptor assay |
| 11/20/2002 | EP1257695A1 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 11/20/2002 | EP1257672A2 Method for detecting and quantifying adenovirus |
| 11/20/2002 | EP1257671A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 11/20/2002 | EP1257670A2 Method for detecting cytosine methylation in dna samples |
| 11/20/2002 | EP1257669A1 Antisense modulation of e2f transcription factor 3 expression |
| 11/20/2002 | EP1257667A2 Electrochemical method for detecting nucleic acids |
| 11/20/2002 | EP1257665A2 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION |
| 11/20/2002 | EP1257663A2 Differential expression screening method |
| 11/20/2002 | EP1257661A1 AN ASSAY FOR DETECTING VARIANT HAPATITIS B VIRUSES (HBVs) WHICH EXHIBIT ALTERED SENSITIVITY TO AGENTS |
| 11/20/2002 | EP1257658A1 Method for increasing the gene expression of transfected genes |
| 11/20/2002 | EP1257657A2 Autoregulatory expression vector for gene therapy |
| 11/20/2002 | EP1257656A2 Recombinant aav packaging systems |
| 11/20/2002 | EP1257655A2 Transgenic plants having resistance to a fungal disease |
| 11/20/2002 | EP1257653A2 Phosphodiesterase type 7b |
| 11/20/2002 | EP1257652A2 Human kinases and polynucleotides encoding the same |
| 11/20/2002 | EP1257651A2 Nucleic acids of the human abc1 gene and applications thereof |
| 11/20/2002 | EP1257650A1 Polymerase compositions and methods of use thereof |
| 11/20/2002 | EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/20/2002 | EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 11/20/2002 | EP1257647A1 Control of membrane traffic |
| 11/20/2002 | EP1257646A2 Transporters and ion channels |
| 11/20/2002 | EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof |
| 11/20/2002 | EP1257644A2 103p2d6: tissue specific protein highly expressed in various cancers |
| 11/20/2002 | EP1257643A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 11/20/2002 | EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses |
| 11/20/2002 | EP1257641A2 Method of modulating glycosylation pathways |
| 11/20/2002 | EP1257640A2 Nucleic acids and polypeptides of drosophila melanogaster snf sodium-neurotransmitter symporter family cell surface receptors and methods of use |
| 11/20/2002 | EP1257639A2 Nucleozymes with endonuclease activity |
| 11/20/2002 | EP1257638A1 Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom |
| 11/20/2002 | EP1257637A2 Sphingosine kinases |
| 11/20/2002 | EP1257636A2 Ozone and/or pathogen-inducible gene expression in plants |
| 11/20/2002 | EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 11/20/2002 | EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 11/20/2002 | EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 11/20/2002 | EP1257584A2 Humanized antibodies that sequester amyloid beta peptide |
| 11/20/2002 | EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use |
| 11/20/2002 | EP1257579A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 11/20/2002 | EP1257578A2 Transporters and ion channels |
| 11/20/2002 | EP1257573A2 New transcription factor carp-2 |
| 11/20/2002 | EP1257572A2 Narc-1, subtilase-like homologs |
| 11/20/2002 | EP1257569A2 Cold-adapted equine influenza viruses |
| 11/20/2002 | EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy |
| 11/20/2002 | EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method |
| 11/20/2002 | EP1257561A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 11/20/2002 | EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 11/20/2002 | EP1257559A1 Mammalian sphingosine-1-phosphate phosphatase |
| 11/20/2002 | EP1257364A2 Container for nucleic acid analysis |
| 11/20/2002 | EP1257355A2 Microarray fabrication techniques and apparatus |
| 11/20/2002 | EP1257354A2 Microarray fabrication techniques and apparatus |
| 11/20/2002 | EP1257295A2 Factor vii or viia-like molecules |
| 11/20/2002 | EP1257292A1 Use of il-18 inhibitors |
| 11/20/2002 | EP1257291A1 Novel antibody with specificity for colon cancer |